Differential effects of curcumin on vasoactive factors in the diabetic rat heart

Nutrition and Metabolism

Volumn 3, Issue , 2006, Pages

  Farhangkhoee, Hana ^a   Khan, Zia A ^a,b   Chen, Shali ^a   Chakrabarti, Subrata ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; CURCUMIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOMYOPATHY; CELL CULTURE; CONTROLLED STUDY; DIABETES MELLITUS; DNA DAMAGE; DRUG EFFECT; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STATISTICAL ANALYSIS; STREPTOZOCIN DIABETES;

EID: 33747344675     PISSN: 17437075     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-3-27     Document Type: Article

References (43)

1. Garcia MJ, McNamara PM, Gordon T, Kannel WB: Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 1974, 23(2):105-111.
2. Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. American Diabetes Association. Diabetes Care 1989, 12(8):573-579.
3. Hayat SA, Patel B, Khattar RS, Malik RA: Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond) 2004, 107(6):539-557.
4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993, 329(14):977-986.
5. United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. Bmj 1995, 310(6972):83-88.
6. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414(6865):813-820.
7. Sheetz MJ, King GL: Molecular understanding of hyperglycemia's adverse effects for diabetic complications. Jama 2002, 288(20):2579-2588.
8. Farhangkhoee H, Khan ZA, Kaur H, Xin X, Chen S, Chakrabarti S: Vascular endothelial dysfunction in diabetic cardiomyopathy: Pathogenesis and potential treatment targets. Pharmacol Ther 2005.
9. Khan ZA, Farhangkhoee H, Chakrabarti S: Towards newer molecular targets for chronic diabetic complications. Curr Vasc Pharmacol 2006, 4(1):45-57.
10. Bonnefont-Rousselot D: Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 2002, 5(5):561-568.
11. Stadler K, Jenei V, von Bolcshazy G, Somogyi A, Jakus J: Increased nitric oxide levels as an early sign of premature aging in diabetes. Free Radic Biol Med 2003, 35(10):1240-1251.
12. Hattori R, Sase K, Eizawa H, Kosuga K, Aoyama T, Inoue R, Sasayama S, Kawai C, Yui Y, Miyahara K, et al.: Structure and function of nitric oxide synthases. Int J Cardiol 1994, 47(1 Suppl):S71-5.
13. Sessa WC: The nitric oxide synthase family of proteins. J Vasc Res 1994, 31(3):131-143.
14. Andrew PJ, Mayer B: Enzymatic function of nitric oxide synthases. Cardiovasc Res 1999, 43(3):521-531.
15. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996, 271(5 Pt 1):C1424-37.
16. Santilli F, Cipollone F, Mezzetti A, Chiarelli F: The role of nitric oxide in the development of diabetic angiopathy. Horm Metab Res 2004, 36(5):319-335.
17. Li H, Forstermann U: Nitric oxide in the pathogenesis of vascular disease. J Pathol 2000, 190(3):244-254.
18. Farhangkhoee H, Khan ZA, Mukherjee S, Cukiernik M, Barbin YP, Karmazyn M, Chakrabarti S: Heme oxygenase in diabetes-induced oxidative stress in the heart. J Mol Cell Cardiol 2003, 35(12):1439-1448.
19. Ammon HP, Wahl MA: Pharmacology of Curcuma longa. Planta Med 1991, 57(1):1-7.
20. Bengmark S: Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J Parenter Enteral Nutr 2006, 30(1):45-51.
21. Arun N, Nalini N: Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum Nutr 2002, 57(1):41-52.
22. Balasubramanyam M, Koteswari AA, Kumar RS, Monickaraj SF, Maheswari JU, Mohan V: Curcumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications. J Biosci 2003, 28(6):715-721.
23. Joe B, Vijaykumar M, Lokesh BR: Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 2004, 44(2):97-111.
24. Singh S, Aggarwal BB: Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 1995, 270(42):24995-25000.
25. Cai L, Chen S, Evans T, Cherian MG, Chakrabarti S: Endothelin-1-mediated alteration of metallothionein and trace metals in the liver and kidneys of chronically diabetic rats. Int J Exp Diabetes Res 2002, 3(3):193-198.
26. Chen S, Evans T, Deng D, Cukiernik M, Chakrabarti S: Hyperhexosemia induced functional and structural changes in the kidneys: role of endothelins. Nephron 2002, 90(1):86-94.
27. Srimal RC, Dhawan BN: Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 1973, 25(6):447-452.
28. Arora RB, Kapoor V, Basu N, Jain AP: Anti-inflammatory studies on Curcuma longa (turmeric). Indian J Med Res 1971, 59(8):1289-1295.
29. Chen S, Mukherjee S, Chakraborty C, Chakrabarti S: High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1. Am J Physiol Cell Physiol 2003, 284(2):C263-72.
30. Pendurthi UR, Williams JT, Rao LV: Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin. Suppression of activation of transcription factors Egr-1, AP-1, and NF-kappa B. Arterioscler Thromb Vasc Biol 1997, 17(12):3406-3413.
31. Mahakunakorn P, Tohda M, Murakami Y, Matsumoto K, Watanabe H, Vajaragupta O: Cytoprotective and cytotoxic effects of curcumin: dual action on H2O2-induced oxidative cell damage in NG108-15 cells. Biol Pharm Bull 2003, 26(5):725-728.
32. Farhangkhoee H, Khan ZA, Barbin Y, Chakrabarti S: Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction. Diabetologia 2005, 48(7):1401-1410.
33. Khan ZA, Barbin YP, Cukiernik M, Adams PC, Chakrabarti S: Hemeoxygenase-mediated iron accumulation in the liver. Can J Physiol Pharmacol 2004, 82(7):448-456.
34. Chen S, Khan ZA, Cukiernik M, Chakrabarti S: Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications. Am J Physiol Endocrinol Metab 2003, 284(6):E1089-97.
35. Jay D, Hitomi H, Griendling KK: Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med 2006, 40(2):183-192.
36. King GL, Loeken MR: Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 2004, 122(4):333-338.
37. Pricci F, Leto G, Amadio L, Iacobini C, Cordone S, Catalano S, Zicari A, Sorcini M, Di Mario U, Pugliese G: Oxidative stress in diabetes-induced endothelial dysfunction involvement of nitric oxide and protein kinase C. Free Radic Biol Med 2003, 35(6):683-694.
38. Aggarwal BB, Kumar A, Bharti AC: Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003, 23(1A):363-398.
39. Pan MH, Lin-Shiau SY, Lin JK: Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochem Pharmacol 2000, 60(11):1665-1676.
40. Brouet I, Ohshima H: Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 1995, 206(2):533-540.
41. Johnston BD, DeMaster EG: Suppression of nitric oxide oxidation to nitrite by curcumin is due to the sequestration of the reaction intermediate nitrogen dioxide, not nitric oxide. Nitric Oxide 2003, 8(4):231-234.
42. Quattrone S, Chiappini L, Scapagnini G, Bigazzi B, Bani D: Relaxin potentiates the expression of inducible nitric oxide synthase by endothelial cells from human umbilical vein in in vitro culture. Mol Hum Reprod 2004, 10(5):325-330.
43. McLean M, Bowman M, Clifton V, Smith R, Grossman AB: Expression of the heme oxygenase-carbon monoxide signalling system in human placenta. J Clin Endocrinol Metab 2000, 85(6):2345-2349.